Keyphrases
Antibody Response
100%
High-risk Human Papillomavirus (HR-HPV)
100%
Human Papillomavirus Vaccine
100%
Inherited Bone Marrow Failure Syndromes
100%
Antibody Level
60%
Fanconi Anemia
60%
Virus-like
60%
Healthy Women
40%
Vaccination
40%
HPV16
40%
HPV18
40%
Unvaccinated
40%
High Risk
20%
IgG Antibody
20%
Head-and-neck Squamous Cell Carcinoma (HNSCC)
20%
Immunization
20%
Enzyme-linked Immunosorbent Assay (ELISA)
20%
Human Papillomavirus Types
20%
Squamous Cell
20%
Cell Head
20%
Gynecologic Carcinoma
20%
Immunology and Microbiology
Antibody Response
100%
Wart Virus
100%
Cervarix
100%
Monospecific Antibody
33%
Vaccination Policy
33%
Human Papillomavirus Type 16
33%
Population
33%
Human Papillomavirus Type 18
33%
Virus Like Particle Vaccine
33%
Vaccine Efficacy
16%
Squamous Cell
16%
Neck
16%
Immunoglobulin G Antibody
16%
Virus-Like Particle
16%